Edward Joseph Quilty

SyntheMed, Inc. engages in the development and commercialization of medical devices for therapeutic applications. It focuses on the development and commercialization of anti-adhesion, drug delivery products and other surgical implants. The company's products and product candidates, which are based on its proprietary, bioresorbable polymer technology, are primarily surgical implants designed to prevent or reduce the formation of adhesions following a broad range of surgical procedures. Its commercialization efforts have been focused on its lead product, REPEL-CV Bioresorbable Adhesion Barrier, for use in cardiac surgery. The company has changed its name from Life Medical Sciences, Inc. to SyntheMed, Inc. in May 2005. It was founded in August 1990 and is headquartered in Iselin, NJ

Part of Becton, Dickinson & Co., MedChem Products, Inc. is a company that produces catheters and surgical products. The company is based in Woburn, MA. MedChem Products was acquired by C. R. Bard, Inc. (New Jersey), part of Becton, Dickinson & Co. from December 29, 2017 on September 28, 1995 for $101.80 million.

Derma Sciences, Inc. is a medical device company. It operates through the following product segments: Advanced Wound Care (AWC), Traditional Wound Care (TWC), and Other. The AWC segment includes both novel and otherwise differentiated dressings, devices, and skin substitutes designed to promote wound healing and prevent infection. The TWC segment focuses on commodity related dressings, ointments, gauze bandages, adhesive bandages, wound closure strips, catheter fasteners, and skin care products. The company was founded on September 10, 1984 and is headquartered in Princeton, NJ.

Vention Medical, Inc. provides surgical and medical instruments and apparatus. The firm specializes in developing interventional and surgical technologies and single-use devices that save or enhance patients lives. The company was founded in 1979 and is headquartered in South Plainfield, NJ.

Gentell, Inc. manufactures and distributes wound, skin and personal care products. The private company is based in Bristol, PA and has subsidiaries in the United States. David Navazio has been the CEO of the company since 2003.

SanMelix Laboratories, Inc. develops bioactive wound dressings and compositions. The firm provides bee cure products. It offers treatment of a variety of wound and dermal afflictions. The company was founded by Kenneth A. Sabacinski, Diana Sabacinski, and John L. Kaufman in 2016 and is headquartered in Hollywood, FL.